News | June 28, 2013

Kettering Medical Center Acquires Elekta’s Versa HD Radiotherapy System

Shorter waiting and treatment times on horizon for western Ohio cancer patients

June 28, 2013 — Kettering Medical Center in Ohio recently began installing Versa HD, an advanced linear accelerator (linac) system designed to improve patient care and treat a wide range of tumors throughout the body. Kettering, a regional center of excellence in stereotactic radiosurgery (SRS) for indications throughout the body, also operates a Leksell Gamma Knife Perfexion system dedicated for SRS in the brain.

According to Douglas Einstein, M.D., Ph.D., chairman of radiation oncology at Kettering, the addition of Versa HD at Kettering Medical Center is the "next evolution" of the clinic's SRS activities over the last several years – which encompasses more than 500 patient treatments – and signifies the center's commitment to providing western Ohio patients with the most advanced techniques available.

Versa HD gives clinicians the flexibility to deliver conventional therapies to treat a broad spectrum of tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision.

"With Versa HD, we believe we can cut total treatment delivery times for our patients in half," Einstein says. "Due to our extensive experience with SRS, many patients travel to Kettering from a distance to receive our state-of-the-art treatments. This technology will allow more patients to be treated per day. Equally important, shorter treatment times will enhance patient comfort.

"Patients undergoing SRS for lung cancer, for example, may have their arms raised for a 30-minute session and that can be difficult," he adds. "We treat many elderly patients who find the SRS treatment time demanding. The High Dose Rate mode of Versa HD will shorten radiation beam delivery time and potentially improve patient comfort in SRS cases.

"The Versa HD MLC will enable even more conformal treatments that should significantly limit normal tissue exposure and decrease side effects. We can deliver these state-of-the-art techniques with Versa HD and do it such a way that it not only manages their cancer, but also minimizes the impact of treatment on their quality of life."

For more information: www.versahd.com

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...